Compounds > 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol
Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and n'-nitrosoanatabine

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with n'-nitrosoanatabine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cheung, F; Errington, G; Kavvadias, D; McEwan, M; Scherer, G; Shepperd, J1
Arnstein, S; Bernert, JT; Blount, BC; Borek, N; Brosius, C; Brown, JL; Chang, CM; Choi, D; Cobos, A; Conway, K; De Castro, BR; Edwards, KC; Ervies, G; Freeman, D; Goniewicz, ML; Guillot, T; Hatsukami, D; Hecht, SS; Hyland, A; Kimmel, HL; Lawrence, C; Lee, J; Li, Y; Nicodemus, K; Pine, BN; Van Bemmel, DM; Wade, EL; Wang, L; Xia, B; Xia, Y1

Other Studies

2 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and n'-nitrosoanatabine

ArticleYear
Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2009, Volume: 14, Issue:8

    Topics: Carcinogens; Humans; Nicotiana; Nitrosamines; Pyridines; Smoke; Smoking

2009
Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2021, 02-16, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Biomarkers; Carcinogens; Female; Humans; Longitudinal Studies; Male; Nitrosamines; Tobacco Use; United States; Young Adult

2021